Gomes Maria Luziene de Sousa, Moura Nádya Dos Santos, Magalhães Letícia de Carvalho, da Silva Roger Rodrigues, Silva Bárbara Gomes Santos, Rodrigues Ivana Rios, Sales Luiz Belino Ferreira, Oriá Mônica Oliveira Batista
Department of Nursing Federal University of Ceara Fortaleza Brazil Department of Nursing, Federal University of Ceara, Fortaleza, Brazil.
Rev Panam Salud Publica. 2023 Jul 3;47:e96. doi: 10.26633/RPSP.2023.96. eCollection 2023.
To identify the 2022 recommendations made by ministries of health in the 13 countries and areas of South America for human papillomavirus (HPV) vaccination and cervical cancer screening.
A systematic review of scientific literature and official documents was conducted between July 7 and October 17, 2022. The review included an initial search on official websites (e.g. ministries of health, national cancer institutes and health departments) of South American countries to identify current guidelines or recommendations for HPV vaccination and cervical cancer screening.
Recommendations for HPV vaccination were found for 11 countries, with the exceptions of French Guiana and the Bolivarian Republic of Venezuela. Recommendations were found for cervical cancer screening in official documents from 11 countries, with the exceptions of the Bolivarian Republic of Venezuela, where one article was found that was not an official recommendation, and Suriname, for which no documents were found on websites or in other publications. A total of 12 countries use cytology to screen for cervical cancer. Four countries (Bolivia [Plurinational State of], Colombia, Guyana and Peru) use visual inspection with acetic acid and the screen-and-treat strategy. Six countries (Argentina, Chile, Colombia, Ecuador, Paraguay and Peru) are transitioning from cytology to HPV testing.
No documents were found about a national HPV vaccination program in French Guiana and Venezuela, and no official guidelines for cervical cancer screening were found for Suriname and Venezuela; thus, it will be difficult to eliminate this public health problem in these countries. Countries in South America must update their guidelines for HPV vaccination and cervical cancer screening as new evidence emerges. Official websites with information about HPV vaccination and cervical cancer screening are important sources that can be accessed by health professionals and the population.
确定南美洲13个国家和地区的卫生部在2022年提出的关于人乳头瘤病毒（HPV）疫苗接种和宫颈癌筛查的建议。
于2022年7月7日至10月17日对科学文献和官方文件进行了系统综述。该综述首先在南美洲国家的官方网站（如卫生部、国家癌症研究所和卫生部门）上进行搜索，以确定当前关于HPV疫苗接种和宫颈癌筛查的指南或建议。
在11个国家发现了HPV疫苗接种建议，法属圭亚那和委内瑞拉玻利瓦尔共和国除外。在11个国家的官方文件中发现了宫颈癌筛查建议，委内瑞拉玻利瓦尔共和国除外，该国仅发现一篇并非官方建议的文章，苏里南也除外，在其网站或其他出版物中均未找到相关文件。共有12个国家使用细胞学方法进行宫颈癌筛查。4个国家（多民族玻利维亚国、哥伦比亚、圭亚那和秘鲁）使用醋酸目视检查和筛查治疗策略。6个国家（阿根廷、智利、哥伦比亚、厄瓜多尔、巴拉圭和秘鲁）正在从细胞学筛查向HPV检测过渡。
在法属圭亚那和委内瑞拉未找到有关国家HPV疫苗接种计划的文件，在苏里南和委内瑞拉未找到宫颈癌筛查的官方指南；因此，在这些国家消除这一公共卫生问题将很困难。随着新证据的出现，南美洲国家必须更新其HPV疫苗接种和宫颈癌筛查指南。提供HPV疫苗接种和宫颈癌筛查信息的官方网站是卫生专业人员和公众可以访问的重要信息来源。
